IPO Confluent (economic model)
Ticker: CFLT Enterprise Platform, which collects and processes data streams in real time. Revenue 2019: 149,8m | 2020: 236,6m | 57.9% 20Q1: 50,9m | 21Q1: 77,0m | 51.
MegaBlog- – this is an amalgamation of posts from popular trading blogs . This section will allow you to track interesting topics and track popular trends in trading., understand what traders live.
Ticker: CFLT Enterprise Platform, which collects and processes data streams in real time. Revenue 2019: 149,8m | 2020: 236,6m | 57.9% 20Q1: 50,9m | 21Q1: 77,0m | 51.
Ticker: DOCS Professional network for doctors with telemedicine and planning tools.
Ticker: CXM Customer Experience Management Software for Companies. Revenue 2019: 324,3m | 2020: 386,9m | 19.3% 20Q1: 93,0m | 21Q1: 111,0m | 19.
Ticker: CYT Develops Small Molecule Treatments, which inhibit the repair of DNA damage.
IPO Verve Therapeutics (economic model) Ticker: VERV Develops One-Year Gene Editing Therapy for Cardiovascular Disease.
12 July Paycor HCM, offering small and midsize businesses a SaaS platform for workforce management, announced the terms of the upcoming IPO. Company headquartered in Cincinnati, Ohio, plans to attract 361 million dollars, releasing 18,5 million shares at a price from 18 to 21 Dollars.
12 July Dynacure, French biotechnology company, developing drugs for the treatment of neuromuscular diseases in the ½ phase of research, announced the terms of the upcoming IPO. Company headquartered in Ilkirsch-Graffenstaden, France, plans to attract 100 million dollars, releasing 6,3 million ADS at a cost of 15 to 17 Dollars.
9 July Rani Therapeutics, developing capsules for oral medication by swallowing, filed an application with the Securities and Exchange Commission to raise up to 100 USD million in initial public offering.
19 July SOPHiA GENETICS, offering a data-driven SaaS platform for the healthcare industry, announced the terms of the upcoming IPO. The company is headquartered in Saint-Sulpice, Switzerland plans to attract 234 million dollars, releasing 13 million shares at a price from 17 to 19 Dollars.
Biotechnology company HCW Biologics, developing new immune drugs for cancer treatment, located in 2 research stage, attracted 56 million dollars, releasing 7,0 million shares in 8 dollars - the minimum price of the stated range from 8 to 10 Dollars.